EVALUATION OF CLUSTERED MICROCALCIFICATIONS, INITIALLY GRADED AS LIKELY MALIGNANT ON BASELINE MAMMOGRAPHY, WITH STEREOTACTIC BIOPSY: A RAD-PATH CORRELATION
Abstract
Background: Stereotactic-guided breast biopsy is an invincible tool to sample abnormalities visible only on mammography with subtle or occult ultrasound findings. Common mammographic abnormalities which require stereotactic core biopsy include calcifications, architectural distortion and satellite lesions. With advancement in techniques for adequate localisation of lesions, the use of stereotactic needle breast biopsy is exponentially increasing. A study was performed to look for frequency of benignancy or malignancy of microcalcifications and architectural distortions in patients initially falling in malignant category of Breast Imaging-Reporting and Data System of American College of Radiology (BI-RADS®) Assessment Categories.
Materials and Methods: Patient presenting in outpatient (OPD) clinic who underwent stereotactic biopsies for labelled malignant on mammograms from May 2015 to May 2018 was included in retrospective study. Age, technique used, baseline mammogram and histopathology were reviewed.
Results: A total of 91 patients underwent stereotactic biopsy. Age range varied between 28 and 81 years. Stereotacticguided biopsies were taken using a standard 14-gauge core needle with long throw of 22 mm excursion. None of the biopsy was inconclusive. In comparison with baseline mammograms and histopathology, 40% of the clusters of microcalcification which were initially labelled as malignant turned out to be malignant on histopathology as well, whereas 60% were reported as benign breast parenchyma.
Conclusion: Agreement between the diagnostic accuracy of microcalcifications on mammogram and histopathology of same lesions after stereotactic biopsy was comparable to international figures with probability of being benign surpassing malignant on routine screening.
Key words: Breast cancer, mammography, microcalcifications, stereotactic biopsy
References
Mahoney MC, Newell MS. Breast intervention: How I do it. Radiology 2013;268:12-24.
Schrading S, Distelmaier M, Dirrichs T, et al. Digital breast tomosynthesis-guided vacuum-assisted breast biopsy: Initial experiences and comparison with prone stereotactic vacuum-assisted biopsy. Radiology 2015;274:654-62.
Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: Determinants of ductal carcinoma in situ underestimation rates. Radiology 2001; 218:497-502.
Jackman RJ, Rodriguez-Soto J. Breast microcalcifications: Retrieval failure at prone stereotactic core and vacuum breast biopsy – frequency, causes, and outcome. Radiology 2006; 239:61-70.
Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radiology 1990;176:741-7.
Meyer JE, Lester SC, Frenna TH, et al. Occult breast calcifications sampled with large-core biopsy: Confirmation with radiography of the specimen. Radiology 1993;188: 581‑2.
Liberman L, Evans WP 3rd, Dershaw DD, et al. Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology 1994;190:223-5.
Welle GJ, Clark M, Loos S, et al. Stereotatic breast biopsy. Am J Roentgenol 2000;175:59-63.
Freer PE, Niell B, Rafferty EA. Preoperative tomosynthesis guided needle localization of mammographically and sonographically occult breast lesions. Radiology 2015;275: 377-83.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.
Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.
